WallStreetZenWallStreetZen

How to Buy Cue Biopharma Stock

Cue Biopharma Inc

Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders.

Cue Biopharma stock last closed at $1.37, down 3.19% from the previous day, and has decreased 65.88% in one year. It has underperformed other stocks in the Biotechnology industry by 0.44 percentage points. Cue Biopharma stock is currently +4.76% from its 52-week low of $1.30, and -73.34% from its 52-week high of $5.12.

As of Apr 26, 2024, there are 48.64M shares of CUE outstanding. The market cap of CUE is $66.40M. In the last 24 hours, 263,686 CUE shares were traded.

How to Buy Cue Biopharma Stock

Not sure how to invest in Cue Biopharma stock? Here's how.
  1. Choose where to buy Cue Biopharma stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Cue Biopharma stock.
  2. Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Put funds into your investment account: Select your payment method and add your details.
  4. Evaluate Cue Biopharma stock: The Cue Biopharma ticker symbol is CUE. Is Cue Biopharma stock a good investment? Should you buy shares of CUE? How do CUE's underlying business fundamentals look? Do top analysts think Cue Biopharma is a good buy? Why has CUE's stock price moved recently? (Hint: Our stock research website can help you decide if CUE is a good stock to buy).
  5. Place your CUE buy order: Decide if you will purchase CUE shares at the current market price or use a limit order to purchase CUE stock at a specific price.
  6. Watch your investment in CUE: Create a watchlist to monitor your position in Cue Biopharma shares.

Step 1: Choose where to buy Cue Biopharma stock

You need an online brokerage account to access the NASDAQ market and buy CUE shares.

A brokerage account allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our analysis, eToro is the best place to buy stocks. Here's why:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to global financial markets: From Tech to Financial Services, New York to Tokyo — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by opening an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected your brokerage, it's time to fill out some personal details so you can invest in CUE stock today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal info to start a new trading account.
  1. Send your information by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you've created your account on stock apps to use, you need to deposit funds:

Check out this video walkthrough if you need help transferring funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Cue Biopharma stock

Once you have selected the best place to buy Cue Biopharma stock, it's important to analyze their stock before you invest, so you truly wrap your head around the risk as well as the upside.

Cue Biopharma stock quick numbers

CUE Price
$1.37
1w %
-12.5%
1y %
-65.88%
5y %
-84.85%
P/E
-1.23x
P/B
1.79x
P/S
11.38x
PEG
N/A
Revenue
$5.49M
Earnings
-$50.73M
Fore. Rev. Growth
62.69%
Fore. Earn. Growth
N/A
Market Cap
$66.40M
Next Earnings
Jun 6, 2024
Next Dividend
N/A

Cue Biopharma Overview

WallStreetZen was created to help everyday investors perform more accurate fundamental analysis quickly.

You can see all of the due diligence checks on CUE's stock page.

Is CUE stock properly valued?

Investors use many financial metrics, analyses, models, and charts to gauge CUE's fair value.

Using relative valuations methods:

  • CUE could be undervalued based on its P/B ratio of 1.79x, relative to Biotechnology industry P/B ratio of 5.85x

You can do more valuation research on CUE's stock here.

CUE Financial Overview

Positive Financial Indicators:

  • There are more short-term assets than long-term liabilities on the CUE balance sheet.
  • There are more short-term assets than short-term liabilities on the CUE balance sheet.
  • CUE has cash burn of 39959000. It has enough cash and short-term investments to cover this for at least one year.

Negative Financial Indicators:

  • CUE has $51.36M in cash and short term investments. This is not enough to cover its annual cash burn of $39.96M.
  • CUE profit margin has gone up by 33.34 percentage points in the past year, but the company is still unprofitable.
  • Total CUE debt is higher than 5 years ago, relative to shareholder equity.
  • CUE has a relatively high debt to equity ratio of 0.66.

Do analysts think it's a good time to buy CUE stock

Out of 4 Wall Street analysts who give ratings on CUE, the consensus analyst rating on Cue Biopharma is a Strong Buy

It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.

You can dig deeper into what analysts are forecasting on the Cue Biopharma stock forecast page.

CUE Momentum

SMA10
1.51
SMA20
1.67
SMA50
1.88
SMA100
2.31
SMA200
2.52
MACD
-0.14
MACD Signal
-0.12
MACD Histogram
-0.02
RSI
30.95
Stochastic %K
9.64
Stochastic %D
8.93
StochRSI %K
0.89
StochRSI %D
7.21

How are CUE Revenues/Earnings doing?

Last year, CUE revenue was $5.49M. Over the last 5 year, CUE's revenue has increased by 36.88% per year. This was faster than the Biotechnology industry average of 28.56%.

You can research CUE's earnings and revenue performance here.

Who is buying/selling CUE?

In the last year, insiders at CUE have bought more shares than they have sold.

Anish Suri, PRESIDENT AND CSO of CUE, was the latest CUE insider to buy. They bought $11,040.00 worth of CUE stock on Aug 25, 2023.

Research more about who owns CUE stock here.

Does CUE provide a stable income stream?

No, Cue Biopharma doesn't provide an income stream by paying out dividends.

Get opinions from other traders

One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Place your CUE buy order

There are two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are mostly fine for most investors.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at an exact price, use a limit order.

Hit the Open Trade button and your broker will place your order.

If you require additional help with buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Watch your investment in CUE

Now that you own some shares in CUE, you'll want to stay up-to-date on your shares.

Create a watchlist to keep track of your CUE stock.

CUE Feed

How to Buy Stock in Cue Biopharma

To reiterate, here are the 6 steps to buy Cue Biopharma stock:

  1. Choose where to buy Cue Biopharma stock
  2. Open your brokerage account
  3. Put funds into your investment account
  4. Evaluate Cue Biopharma stock
  5. Place your CUE buy order
  6. Watch your investment in CUE

If you are looking for a online brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep tabs on your new investment in Cue Biopharma, add CUE to your watchlist by clicking the button below.

NASDAQ: CUE
$1.37-0.05 (-3.19%)
Updated Apr 26, 2024
Open eToro Account
NASDAQ: CUE
$1.37-0.05 (-3.19%)
Updated Apr 26, 2024
Open eToro Account

FAQ

How much does it cost to buy one Cue Biopharma share?

As of Apr 26, 2024, it costs $1.37 to buy one share of Cue Biopharma stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.68, you can buy 0.5 shares of CUE.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Cue Biopharma stock?

According to 4 Wall Street analysts who monitor Cue Biopharma, their consensus recommendation is to buy Cue Biopharma stock.

What is the best way to buy Cue Biopharma stock?

One way to place an order for Cue Biopharma stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.